Literature DB >> 10704526

Microanalysis of enzyme digests of hyaluronan and chondroitin/dermatan sulfate by fluorophore-assisted carbohydrate electrophoresis (FACE).

A Calabro1, M Benavides, M Tammi, V C Hascall, R J Midura.   

Abstract

Hyaluronan and chondroitin/dermatan sulfate are glycosaminoglycans that play major roles in the biomechanical properties of a wide variety of tissues, including cartilage. A chondroitin/dermatan sulfate chain can be divided into three regions: (1) a single linkage region oligosaccharide, through which the chain is attached to its proteoglycan core protein, (2) numerous internal repeat disaccharides, which comprise the bulk of the chain, and (3) a single nonreducing terminal saccharide structure. Each of these regions of a chondroitin/dermatan sulfate chain has its own level of microheterogeneity of structure, which varies with proteoglycan class, tissue source, species, and pathology. We have developed rapid, simple, and sensitive protocols for detection, characterization and quantitation of the saccharide structures from the internal disaccharide and nonreducing terminal regions of hyaluronan and chondroitin/dermatan sulfate chains. These protocols rely on the generation of saccharide structures with free reducing groups by specific enzymatic treatments (hyaluronidase/chondroitinase) which are then quantitatively tagged though their free reducing groups with the fluorescent reporter, 2-aminoacridone. These saccharide structures are further characterized by modification through additional enzymatic (sulfatase) or chemical (mercuric ion) treatments. After separation by fluorophore-assisted carbohydrate electrophoresis, the relative fluorescence in each band is quantitated with a cooled, charge-coupled device camera for analysis. Specifically, the digestion products identified are (1) unsaturated internal Deltadisaccharides including DeltaDiHA, DeltaDi0S, DeltaDi2S, DeltaDi4S, DeltaDi6S, DeltaDi2,4S, DeltaDi2,6S, DeltaDi4,6S, and DeltaDi2,4,6S; (2) saturated nonreducing terminal disaccharides including DiHA, Di0S, Di4S and Di6S; and (3) nonreducing terminal hexosamines including glcNAc, galNAc, 4S-galNAc, 6S-galNAc, and 4, 6S-galNAc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10704526     DOI: 10.1093/glycob/10.3.273

Source DB:  PubMed          Journal:  Glycobiology        ISSN: 0959-6658            Impact factor:   4.313


  60 in total

1.  Disruption of hyaluronan synthase-2 abrogates normal cardiac morphogenesis and hyaluronan-mediated transformation of epithelium to mesenchyme.

Authors:  T D Camenisch; A P Spicer; T Brehm-Gibson; J Biesterfeldt; M L Augustine; A Calabro; S Kubalak; S E Klewer; J A McDonald
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

2.  Hyaluronan is not elevated in urine or serum in Hutchinson-Gilford Progeria Syndrome.

Authors:  Leslie B Gordon; Ingrid A Harten; Anthony Calabro; Geetha Sugumaran; Antonei B Csoka; W Ted Brown; Vincent Hascall; Bryan P Toole
Journal:  Hum Genet       Date:  2003-05-01       Impact factor: 4.132

3.  Biosynthesis of heparan sulphate with diverse structures and functions: two alternatively spliced forms of human heparan sulphate 6-O-sulphotransferase-2 having different expression patterns and properties.

Authors:  Hiroko Habuchi; Goichiro Miyake; Ken Nogami; Asato Kuroiwa; Yoichi Matsuda; Marion Kusche-Gullberg; Osami Habuchi; Masayuki Tanaka; Koji Kimata
Journal:  Biochem J       Date:  2003-04-01       Impact factor: 3.857

4.  Age-related differences in human skin proteoglycans.

Authors:  David A Carrino; Anthony Calabro; Aniq B Darr; Maria T Dours-Zimmermann; John D Sandy; Dieter R Zimmermann; J Michael Sorrell; Vincent C Hascall; Arnold I Caplan
Journal:  Glycobiology       Date:  2010-10-14       Impact factor: 4.313

5.  Changes of large molecular weight hyaluronan and versican in the mouse pubic symphysis through pregnancy.

Authors:  Renata Giardini Rosa; Yucel Akgul; Paulo Pinto Joazeiro; Mala Mahendroo
Journal:  Biol Reprod       Date:  2012-02-29       Impact factor: 4.285

6.  Airway smooth muscle cells synthesize hyaluronan cable structures independent of inter-alpha-inhibitor heavy chain attachment.

Authors:  Mark E Lauer; Csaba Fulop; Durba Mukhopadhyay; Suzy Comhair; Serpil C Erzurum; Vincent C Hascall
Journal:  J Biol Chem       Date:  2008-12-15       Impact factor: 5.157

7.  Tandem mass spectrometric strategies for determination of sulfation positions and uronic acid epimerization in chondroitin sulfate oligosaccharides.

Authors:  Joseph Zaia; Xue-Qing Li; Shiu-Yung Chan; Catherine E Costello
Journal:  J Am Soc Mass Spectrom       Date:  2003-11       Impact factor: 3.109

8.  Synthesis and characterization of tyramine-based hyaluronan hydrogels.

Authors:  Aniq Darr; Anthony Calabro
Journal:  J Mater Sci Mater Med       Date:  2008-07-31       Impact factor: 3.896

9.  Modulation of hyaluronan production by CD44 positive glioma cells.

Authors:  Marzenna Wiranowska; Sharron Ladd; Lynn C Moscinski; Bobbye Hill; Ed Haller; Katalin Mikecz; Anna Plaas
Journal:  Int J Cancer       Date:  2010-08-01       Impact factor: 7.396

10.  Platelet-derived hyaluronidase 2 cleaves hyaluronan into fragments that trigger monocyte-mediated production of proinflammatory cytokines.

Authors:  Carol de la Motte; Julie Nigro; Amit Vasanji; Hyunjin Rho; Sean Kessler; Sudip Bandyopadhyay; Silvio Danese; Claudio Fiocchi; Robert Stern
Journal:  Am J Pathol       Date:  2009-05-14       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.